iCoreConnect (ICCT) & The Competition Head-To-Head Contrast

Volatility and Risk

iCoreConnect has a beta of 0.69, meaning that its share price is 31% less volatile than the S&P 500. Comparatively, iCoreConnect’s peers have a beta of 0.43, meaning that their average share price is 57% less volatile than the S&P 500.

Valuation and Earnings

This table compares iCoreConnect and its peers revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
iCoreConnect	$8.15 million	-$15.55 million	-0.06
iCoreConnect Competitors	$2.07 billion	$337.89 million	5.46

iCoreConnect’s peers have higher revenue and earnings than iCoreConnect. iCoreConnect is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Insider & Institutional Ownership

13.4% of iCoreConnect shares are owned by institutional investors. Comparatively, 56.9% of shares of all “Prepackaged software” companies are owned by institutional investors. 59.4% of iCoreConnect shares are owned by insiders. Comparatively, 18.9% of shares of all “Prepackaged software” companies are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Profitability

This table compares iCoreConnect and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
iCoreConnect	-260.79%	-614.22%	-152.86%
iCoreConnect Competitors	-59.69%	-28.77%	-7.76%

Summary

iCoreConnect peers beat iCoreConnect on 7 of the 9 factors compared.

iCoreConnect Company Profile

iCoreConnect Inc., a cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States. The company’s products include iCoreRx, a HIPAA compliant electronic prescription software; iCorePDMP, a solution that checks the patient’s Prescription Drug Monitoring Program (PDMP) history before prescribing controlled substances; iCoreVerify and iCoreVerify+, a HIPAA compliant SaaS solution that automatically retrieves a patients insurance eligibility breakdown to verify their benefits in advance of their appointment and on-demand; iCoreHuddle and iCoreHuddle+, a tool to instantly reveal the revenue potential of each patient; and iCoreCodeGenius, a medical coding reference SaaS solution. It also offers iCoreExchange, a SaaS email solution that allows doctors to send and receive secure email with attachments to and from other healthcare professionals; iCoreCloud, ability to backup their on-premise servers and computers to the cloud; iCoreClaims, for processing and managing claims submitted by policyholders or dental care providers; iCorePay, a patient payment processing solutions for payment and revenue cycle tracking; iCoreSecure, secure SaaS solution that solves privacy concerns in the insurance, real estate, financial and many other industry sectors; and iCoreIT, an IT managed services. The company was formerly known as iMedicor, Inc. and changed its name to iCoreConnect Inc. in June 2017. iCoreConnect Inc. was founded in 1992 and is headquartered in Ocoee, Florida.